|
27
|
82
|
9rzkB |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
97
|
9rznA |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
27
|
82
|
9rznB |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
37
|
95
|
9rzkD |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
97
|
9rzkA |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
106
|
9rzkC |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
36
|
95
|
9rznD |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
32
|
106
|
9rznC |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
26
|
109
|
10goC |
Nucleosome containing an 8oxog at shl+2 |
|
33
|
94
|
10gmD |
Nucleosome containing an 8oxog:a at shl+2 |
|
24
|
83
|
10glB |
Nucleosome containing an 8oxog:a at shl+3 |
|
29
|
108
|
10gjC |
Nucleosome containing an 8oxog:a at shl-6 |
|
27
|
109
|
10gmC |
Nucleosome containing an 8oxog:a at shl+2 |
|
27
|
98
|
10gkA |
Nucleosome containing an 8oxog:a at shl+4 |
|
32
|
106
|
9rxvC |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
34
|
95
|
9ry3D |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
27
|
82
|
9rxuB |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
29
|
98
|
10glA |
Nucleosome containing an 8oxog:a at shl+3 |
|
26
|
96
|
10gmA |
Nucleosome containing an 8oxog:a at shl+2 |
|
32
|
93
|
10gjD |
Nucleosome containing an 8oxog:a at shl-6 |
|
30
|
93
|
10gnD |
Nucleosome containing an 8oxog at shl+3 |
|
38
|
95
|
9rxuD |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
21
|
81
|
10gnB |
Nucleosome containing an 8oxog at shl+3 |
|
27
|
96
|
10goA |
Nucleosome containing an 8oxog at shl+2 |
|
27
|
81
|
10gkB |
Nucleosome containing an 8oxog:a at shl+4 |
|
30
|
97
|
9ry3A |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
26
|
96
|
10gjA |
Nucleosome containing an 8oxog:a at shl-6 |
|
32
|
106
|
9ry3C |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
23
|
80
|
10gjB |
Nucleosome containing an 8oxog:a at shl-6 |
|
31
|
93
|
10gkD |
Nucleosome containing an 8oxog:a at shl+4 |
|
32
|
106
|
9ryaC |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
94
|
10glD |
Nucleosome containing an 8oxog:a at shl+3 |
|
26
|
97
|
10gnA |
Nucleosome containing an 8oxog at shl+3 |
|
24
|
81
|
10gmB |
Nucleosome containing an 8oxog:a at shl+2 |
|
35
|
95
|
9rxvD |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
34
|
106
|
9rxuC |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
35
|
95
|
9ryaD |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
25
|
108
|
10gnC |
Nucleosome containing an 8oxog at shl+3 |
|
24
|
82
|
10goB |
Nucleosome containing an 8oxog at shl+2 |
|
29
|
109
|
10glC |
Nucleosome containing an 8oxog:a at shl+3 |
|
28
|
108
|
10gkC |
Nucleosome containing an 8oxog:a at shl+4 |
|
33
|
94
|
10goD |
Nucleosome containing an 8oxog at shl+2 |
|
31
|
97
|
9ryaA |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
32
|
97
|
9rxuA |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
28
|
82
|
9ry3B |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
27
|
82
|
9rxvB |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
28
|
82
|
9ryaB |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
97
|
9rxvA |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
283
|
847
|
9t4vK |
Alc1/chd1l in an intermediate conformation, bound to a parylated nucleosome |
|
28
|
98
|
9y47A |
Human nucleosome structure on nickel-nta lipid affinity grid (c1 refinement) |
